What is Polarean Imaging?
Polarean Imaging is a medical technology firm dedicated to transforming the landscape of lung diagnostics. At the core of its value proposition is the utilization of Xenon MRI technology, which allows for the visualization of lung ventilation during a brief breath-hold. Unlike conventional imaging modalities that may involve ionizing radiation, Polarean's approach offers a safer, more detailed alternative for assessing pulmonary health. The company's comprehensive product ecosystem includes specialized gas blends, hyperpolarizers, and dedicated chest coils, all engineered to integrate seamlessly into existing clinical workflows. By focusing on high-resolution, functional imaging, Polarean addresses a significant unmet need in the diagnostic market, particularly for patients suffering from complex, chronic respiratory diseases.
How much funding has Polarean Imaging raised?
Polarean Imaging has raised a total of $126.2M across 2 funding rounds:
Debt
$150K
Other Financing Round
$126M
Debt (2020): $150K with participation from PPP
Other Financing Round (2024): $126M led by Bracco Group and NUKEM Isotopes
Key Investors in Polarean Imaging
Bracco Group
The Bracco Group is an international leader in diagnostic imaging, providing a comprehensive portfolio of contrast media and medical devices to the global healthcare sector.
NUKEM Isotopes
NUKEM Isotopes is a specialized trading firm focused on the supply and distribution of stable isotopes, ensuring high-purity noble gases for industrial and medical applications.
PPP
Public-Private Partnership
What's next for Polarean Imaging?
With the support of this major strategic investment, Polarean Imaging is well-positioned to expand its clinical footprint and deepen its research initiatives. The company's roadmap likely involves scaling the commercial deployment of its hyperpolarizer systems and strengthening its supply chain for specialized gas components. Furthermore, the focus will remain on validating the efficacy of Xenon MRI across a broader spectrum of respiratory conditions, potentially unlocking new diagnostic applications. As the company transitions into this next phase of growth, the emphasis will be on operational excellence and the continued integration of its technology into global healthcare systems, ensuring that clinicians have the tools required to improve patient outcomes in the face of rising respiratory health challenges.
See full Polarean Imaging company page
